CDLX
VENTE TOTALE: 13 461 titres (~53 820,27 $ US)
- Insiders
- Gupta Amit
- Total bought
- —
- Total sold
- $53,820
- Last activity
- 2026-08-18
- Last synced
-
2026-08-25 17:08:49
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-08-26
CDLX presents a deeply concerning financial profile with persistent operating losses, negative EBITDA, and a fragile capital structure that renders the 40 liquidity score largely superficial.
The first sentence of the analysis written for CDLX on 2026-08-26 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 45.0% | 43.4% | 42.2% | 37.7% | 38.7% | |
| Ebit Margin | -39.8% | -64.8% | -41.6% | -155.5% | -46.4% | |
| Ebitda Margin | -28.1% | -54.8% | -32.0% | -140.8% | -33.0% | |
| Operating Profit Margin | -20.2% | -70.2% | -43.9% | -153.3% | -45.9% | |
| Pretax Profit Margin | -44.4% | -68.0% | -43.6% | -156.3% | -51.1% | |
| Continuous Operations Profit Margin | -44.4% | -68.0% | -43.6% | -155.8% | -48.1% | |
| Net Profit Margin | -44.4% | -68.0% | -43.6% | -155.8% | -48.1% | |
| Bottom Line Profit Margin | -44.4% | -68.0% | -43.6% | -155.8% | -48.1% | |
| Current Ratio | 1.751 | 1.195 | 1.308 | 1.004 | 1.096 | |
| Quick Ratio | 1.751 | 1.195 | 1.308 | 1.004 | 1.096 | |
| Solvency Ratio | -0.260 | -0.500 | -0.239 | -0.879 | -0.162 | |
| Cash Ratio | 0.621 | 0.440 | 0.537 | 0.490 | 0.713 | |
| Price To Earnings Ratio | -0.590 | -0.949 | -2.496 | -0.415 | -16.564 | |
| Price To Earnings Growth Ratio | 0.012 | -0.159 | 0.034 | -0.002 | -0.194 | |
| Forward Price To Earnings Growth Ratio | 0.012 | -0.159 | 0.034 | -0.002 | -0.194 | |
| Price To Earnings Diluted Ratio | -0.590 | -0.949 | -2.496 | -0.415 | -16.564 | |
| Price To Earnings Diluted Growth Ratio | 0.012 | -0.159 | 0.034 | -0.002 | -0.194 | |
| Price To Book Ratio | -9.386 | 2.563 | 2.493 | 0.913 | 3.081 | |
| Price To Sales Ratio | 0.262 | 0.645 | 1.087 | 0.647 | 7.967 | |
| Price To Free Cash Flow Ratio | -9.409 | -6.380 | -26.720 | -2.866 | -41.659 | |
| Price To Operating Cash Flow Ratio | 6.575 | -20.333 | -1,816.511 | -3.583 | -55.246 | |
| Debt To Assets Ratio | 0.754 | 0.564 | 0.463 | 0.340 | 0.156 | |
| Debt To Equity Ratio | -33.085 | 3.167 | 1.974 | 1.112 | 0.286 | |
| Debt To Capital Ratio | 1.031 | 0.760 | 0.664 | 0.526 | 0.222 | |
| Long Term Debt To Capital Ratio | 1.032 | 0.706 | 0.656 | 0.516 | 0.211 | |
| Financial Leverage Ratio | -43.891 | 5.611 | 4.259 | 3.267 | 1.830 | |
| Working Capital Turnover Ratio | 5.307 | 6.804 | 11.478 | 18.387 | 1.591 | |
| Operating Cash Flow Ratio | 0.119 | -0.059 | -0.001 | -0.217 | -0.118 | |
| Operating Cash Flow Sales Ratio | 0.040 | -0.032 | -0.001 | -0.181 | -0.144 | |
| Free Cash Flow Operating Cash Flow Ratio | -0.699 | 3.187 | 67.984 | 1.250 | 1.326 | |
| Debt Service Coverage Ratio | -6.157 | -2.785 | -15.986 | -104.899 | -6.248 | |
| Interest Coverage Ratio | -4.435 | -21.959 | -21.942 | -114.616 | -9.533 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | -0.192 | -18.500 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.043 | -0.040 | -0.001 | -0.229 | -0.195 | |
| Capital Expenditure Coverage Ratio | 0.589 | -0.457 | -0.015 | -3.997 | -3.066 | |
| Dividend Paid And Capex Coverage Ratio | 0.589 | -0.457 | -0.015 | -3.997 | -3.066 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -3.479 | -2.199 | -5.155 | -0.729 | -23.715 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 45.1% | ▲1.6% | ▲3.6% |
| Ebit Margin | -39.8% | ▲25.0% | ▲29.8% |
| Ebitda Margin | -28.1% | ▲26.8% | ▲29.7% |
| Operating Profit Margin | -20.2% | ▲50.0% | ▲46.5% |
| Pretax Profit Margin | -44.4% | ▲23.7% | ▲28.3% |
| Continuous Operations Profit Margin | -44.4% | ▲23.7% | ▲27.6% |
| Net Profit Margin | -44.4% | ▲23.7% | ▲27.6% |
| Bottom Line Profit Margin | -44.4% | ▲23.7% | ▲27.6% |
| Current Ratio | 1.751 | ▲0.556 | ▲0.480 |
| Quick Ratio | 1.751 | ▲0.556 | ▲0.480 |
| Solvency Ratio | -0.260 | ▲0.240 | ▲0.148 |
| Cash Ratio | 0.622 | ▲0.181 | ▲0.061 |
| Price To Earnings Ratio | -0.590 | ▲0.359 | ▲3.613 |
| Price To Earnings Growth Ratio | 0.012 | ▲0.171 | ▲0.073 |
| Forward Price To Earnings Growth Ratio | 0.012 | ▲0.171 | ▲0.073 |
| Price To Earnings Diluted Ratio | -0.590 | ▲0.359 | ▲3.613 |
| Price To Earnings Diluted Growth Ratio | 0.012 | ▲0.171 | ▲0.073 |
| Price To Book Ratio | -9.386 | ▼-11.949 | ▼-9.319 |
| Price To Sales Ratio | 0.262 | ▼-0.383 | ▼-1.860 |
| Price To Free Cash Flow Ratio | -9.409 | ▼-3.029 | ▲7.998 |
| Price To Operating Cash Flow Ratio | 6.575 | ▲26.908 | ▲384.394 |
| Debt To Assets Ratio | 0.754 | ▲0.189 | ▲0.298 |
| Debt To Equity Ratio | -33.084 | ▼-36.251 | ▼-27.775 |
| Debt To Capital Ratio | 1.031 | ▲0.271 | ▲0.391 |
| Long Term Debt To Capital Ratio | 1.032 | ▲0.327 | ▲0.408 |
| Financial Leverage Ratio | -43.891 | ▼-49.502 | ▼-38.106 |
| Working Capital Turnover Ratio | 5.307 | ▼-1.497 | ▼-3.407 |
| Operating Cash Flow Ratio | 0.118 | ▲0.178 | ▲0.174 |
| Operating Cash Flow Sales Ratio | 0.040 | ▲0.071 | ▲0.103 |
| Free Cash Flow Operating Cash Flow Ratio | -0.699 | ▼-3.886 | ▼-15.309 |
| Debt Service Coverage Ratio | -6.157 | ▼-3.372 | ▲21.058 |
| Interest Coverage Ratio | -4.435 | ▲17.524 | ▲30.062 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | ▲0.192 | ▲3.739 |
| Operating Cash Flow Coverage Ratio | 0.043 | ▲0.083 | ▲0.128 |
| Capital Expenditure Coverage Ratio | 0.589 | ▲1.046 | ▲1.978 |
| Dividend Paid And Capex Coverage Ratio | 0.589 | ▲1.046 | ▲1.978 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -3.479 | ▼-1.279 | ▲3.577 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $61.1M | $179.4M | $336.1M | $193.2M | $2.13B | |
| Enterprise value | $227.7M | $335.5M | $510.3M | $306.5M | $2.09B | |
| EV / Sales | 0.98x | 1.21x | 1.65x | 1.03x | 7.83x | |
| EV / Op. cash flow | 24.51x | -38.02x | -2758.54x | -5.69x | -54.30x | |
| EV / Free cash flow | -35.07x | -11.93x | -40.58x | -4.55x | -40.95x | |
| EV / EBITDA | -3.48x | -2.20x | -5.16x | -0.73x | -23.71x | |
| Net debt / EBITDA | -2.54x | -1.02x | -1.76x | -0.27x | 0.41x | |
| Current ratio | 1.75x | 1.20x | 1.31x | 1.00x | 1.10x | |
| Income quality | -0.09x | 0.05x | 0.00x | 0.12x | 0.30x | |
| Graham net-net | -$34 | -$37 | -$69 | -$80 | -$78 | |
| Tax burden | 100.0% | 100.0% | 100.0% | 99.7% | 94.2% | |
| Interest burden | 111.4% | 104.9% | 104.8% | 100.6% | 110.1% | |
| Working capital | $58.9M | $29.0M | $52.8M | $1.1M | $31.4M | |
| Invested capital | $181.7M | $208.8M | $400.3M | $439.7M | $934.0M | |
| Return on assets | -36.2% | -48.2% | -23.5% | -67.3% | -10.2% | |
| Operating ROA | -13.9% | -40.4% | -21.4% | -46.8% | -14.5% | |
| Return on tangible assets | -61.0% | -85.3% | -56.8% | -175.5% | -33.6% | |
| Return on equity | 1590.2% | -270.5% | -99.9% | -219.9% | -18.6% | |
| Return on invested capital | -22.6% | -67.0% | -33.5% | -102.0% | -12.3% | |
| Return on capital employed | -22.7% | -80.2% | -33.7% | -103.5% | -13.1% | |
| Earnings yield | -169.4% | -105.5% | -40.1% | -240.9% | -6.0% | |
| Free cash flow yield | -10.6% | -15.7% | -3.7% | -34.9% | -2.4% | |
| Capex / Op. cash flow | 169.9% | -218.7% | -6698.4% | -25.0% | -32.6% | |
| Capex / Depreciation | 57.6% | 69.2% | 42.0% | 30.8% | 35.2% | |
| Capex / Sales | 6.8% | 6.9% | 4.0% | 4.5% | 4.7% | |
| SG&A / Sales | 37.2% | 39.2% | 37.6% | 52.3% | 49.5% | |
| R&D / Sales | 17.0% | 17.8% | 16.6% | 18.2% | 14.3% | |
| Stock comp / Sales | 12.1% | 14.5% | 13.3% | 15.0% | 18.8% | |
| Intangibles / Total assets | 40.6% | 43.5% | 58.7% | 61.6% | 69.7% | |
| Days sales outstanding | 133d | 140d | 149d | 147d | 160d | |
| Days payables outstanding | 10d | 9d | 9d | 7d | 10d | |
| Operating cycle | 133d | 140d | 149d | 147d | 160d | |
| Cash conversion cycle | 124d | 132d | 140d | 139d | 150d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-66.0%EV / Sales ▼-19.0%EV / EBITDA ▼-58.2%EV / Op. cash flow ▲+62.526Earnings yield ▼-0.639
Profitability
Return on equity ▲+18.606Return on assets ▲+0.120Return on invested capital ▲+0.445Return on capital employed ▲+0.575Operating ROA ▲+0.265Income quality ▼-0.136Tax burden 0.000
Efficiency
Days sales outstanding ▼-7.005Days payables outstanding ▲+1.012Operating cycle ▼-7.005Cash conversion cycle ▼-8.018Capex / Sales ▼-0.002R&D / Sales ▼-0.008
Balance-sheet strength
Current ratio ▲+0.556Net debt / EBITDA ▼-1.522Working capital ▲+29861000.000Invested capital ▼-27046000.000Intangibles / Total assets ▼-0.029
Change over 5 years
Valuation
Market cap ▼-97.1%EV / Sales ▼-87.5%EV / EBITDA ▲+85.3%EV / Op. cash flow ▲+78.813Earnings yield ▼-1.634
Profitability
Return on equity ▲+16.088Return on assets ▼-0.261Return on invested capital ▼-0.103Return on capital employed ▼-0.097Operating ROA ▲+0.006Income quality ▼-0.389Tax burden ▲+0.058
Efficiency
Days sales outstanding ▼-26.724Days payables outstanding ▼-0.727Operating cycle ▼-26.724Cash conversion cycle ▼-25.996Capex / Sales ▲+0.021R&D / Sales ▲+0.028
Balance-sheet strength
Current ratio ▲+0.655Net debt / EBITDA ▼-2.956Working capital ▲+27514000.000Invested capital ▼-752322000.000Intangibles / Total assets ▼-0.292
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-06 Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call Transcript Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call Transcript
- 2026-08-05 Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX), a purchase intelligence platform, today announced financial results for the second quarter ended June 30, 2026. "The second quarter shows that our execution is translating directly into results. We were within our guidance across all key metrics, with margins improving every single month of the quarter,” said Amit Gupta, CEO of Cardlytics. “We added new advertiser relationships and deepened our partnerships with existing financial insti.
- 2026-08-03 Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) announced that on Aug. 3, 2026, Cardlytics granted an aggregate of 50,000 restricted stock units of Cardlytics to its newly appointed Chief Legal Officer, Chris Cheng. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). The restricted stock units shall v.
- 2026-07-31 Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on July 29, 2026, the Compensation Committee of Cardlytics'' Board of Directors granted an aggregate of 10,320 restricted stock units of Cardlytics to 10 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). For a.
- 2026-07-29 Cardlytics Appoints Chris Cheng as Chief Legal Officer ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the appointment of Chris Cheng as Chief Legal Officer, effective August 3, 2026. Cheng will serve on the Leadership Team and oversee Cardlytics Legal and Compliance organization. Cheng brings more than 20 years of legal leadership experience at high-growth technology companies, with deep expertise supporting public companies and partnering with executive teams during periods of transformation. With senior legal experience.
- 2026-07-21 Cardlytics to Report Second Quarter 2026 Results on August 5 [url="]Cardlytics, Inc.[/url] (NASDAQ: CDLX) today announced that its financial results for the second quarter ending June 30, 2026 will be released on August
- 2026-07-21 Cardlytics to Report Second Quarter 2026 Results on August 5 ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the second quarter ending June 30, 2026 will be released on August 5, 2026, after market close. Conference Call Details: When: August 5, 2026 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the.